<乌鸦传媒>Ofatumumab Cuts MS Relapse Rates, New Brain Lesions Anti-CD20 monoclonal antibody poised to take on ocrelizumab Sep 16, 2019
<乌鸦传媒>Ponesimod Bests Aubagio in Head-to-Head MS Trial Investigational drug reduces annual relapse rate, shows effects on fatigue Sep 12, 2019
<乌鸦传媒>IL-6 Inhibitor Cuts NMO Relapse Rates Satralizumab reduces attacks in neuromyelitis optica spectrum disorder Sep 11, 2019
<乌鸦传媒>Chronic, Active Lesions Tied to More Aggressive MS Smoldering inflammation seen even in patients treated with effective disease-modifying therapies Aug 12, 2019
<乌鸦传媒>Early MS Scans Predict Long-Term Outcomes MRI lesions seen 15 years prior linked to secondary progression and disability Jul 26, 2019
<乌鸦传媒>2019: 'The Year of NMO' Three different drugs report lower relapse rates in neuromyelitis optica spectrum disorder May 10, 2019
<乌鸦传媒>Bone Marrow Transplant for Autoimmune Disease: Ready for Prime Time? Everything you know about BMT is probably wrong, says hematologist Apr 08, 2019
<乌鸦传媒>Sugary Drinks May Up Disability in MS But overall diet quality not associated with disability status Mar 05, 2019
<乌鸦传媒>Can MS Treatment Be Stopped? Pendulum keeps swinging on risks from drug discontinuation Mar 04, 2019
<乌鸦传媒>Alemtuzumab Benefits Persist in Multiple Sclerosis Many patients did not need additional treatment after first two courses of the drug Mar 03, 2019
<乌鸦传媒>Early Serum NfL Tied to Long-Term MS Brain Changes Early axonal damage may identify multiple sclerosis patients at risk for more severe disease Mar 01, 2019
<乌鸦传媒>Study Raises Questions on Nuedexta Prescribing Real-world data show PBA drug given mainly to dementia and Parkinson's disease patients Jan 07, 2019
<乌鸦传媒>Machine Learning Allows for Low-Dose Gadolinium Contrast Minimal loss of resolution with 10% Gd dose Nov 30, 2018
<乌鸦传媒>Elephants and Alzheimer's; Omega-3 and Epilepsy; Eye Disease and Dementia News and commentary from the world of neurology and neuroscience Aug 14, 2018
<乌鸦传媒>Calif. Medical Board Acts on Doc With Risky MS 'Cure' Physician featured in States of Disgrace series Jul 31, 2018
<乌鸦传媒>Some Multiple Sclerosis Agents May be Safe During Pregnancy Stopping treatment may put MS patients at unnecessary risk Jun 05, 2018
<乌鸦传媒>Still No Clarity on Role of Vitamin D in MS Relapse But findings do help estimate needed sample size for a future prospective study Jun 04, 2018
<乌鸦传媒>MRI Improvements in MS with Switch from IFN to Ocrelizumab Rapid and robust reduction in activity Jun 04, 2018
<乌鸦传媒>When Is the Ideal Time for Some MS Patients to Start DMT? Unclear benefits with disease-modifying therapies in older patients, asymptomatic patients Jun 03, 2018
<乌鸦传媒>Twice-a-Week IFN Dose an Option in Breakthrough MS Nearly two decades of data showed good outcomes Jun 02, 2018
<乌鸦传媒>Biologic for MS Linked to Reduced Vaccine Response Ocrelizumab treatment associated with decreased humoral response Jun 01, 2018
<乌鸦传媒>AAN 2018: Rare Disease Breakthroughs and Novel Approaches Noteworthy presentations at American Academy of Neurology meeting Apr 20, 2018
<乌鸦传媒>Docs, Medical Boards Ignored FDA Warning Letters on CCSVI Fueled by YouTube, bogus MS 'cure' peddled by docs licensed in multiple states Mar 28, 2018
<乌鸦传媒>Coffee and Cannabis; Stephen Hawking鈥檚 ALS; New Stroke Risk Loci News and commentary from the world of neurology and neuroscience Mar 20, 2018
<乌鸦传媒>NeuroBreak: Hits, Not Concussions, Cause CTE; Smoking and PD; APOE4 News News and commentary from the world of neurology and neuroscience Jan 23, 2018
<乌鸦传媒>Zamboni Stands By CCSVI Theory of MS His own RCT turns up negative, but he vows to fight on as MS community moves on Dec 26, 2017
<乌鸦传媒>New Immunoglobulin May Tell of MS Disease Severity Preliminary study implicates IgA in MS disease activity for first time Nov 15, 2017
<乌鸦传媒>Protein May Be Marker of MS Disease Severity, Remyelination Early work suggests beneficial effect of IL4I1 in multiple sclerosis Nov 13, 2017
<乌鸦传媒>Anti-Inflammatory Drug May Offer Benefit in Progressive MS Ibudilast seems to diminish brain volume loss Oct 29, 2017
<乌鸦传媒>Strike Three for Laquinimod in Relapsing MS Switching endpoints for third phase III trial didn't help Oct 27, 2017
<乌鸦传媒>Getting a Handle on Benign MS Prevalence varies by definition; agreed that disease progression varies widely Oct 27, 2017
<乌鸦传媒>Vaccines Tied to Relapses in Neuromyelitis Optica Retrospective review finds protective factor in immunotherapy Oct 26, 2017
<乌鸦传媒>Revised McDonald Diagnostic Criteria Revealed Recommends using OCBs, both symptomatic and asymptomatic lesions to diagnose MS Oct 26, 2017
<乌鸦传媒>FDA Panel Backs New Warning for Gadolinium Contrast Agents Manufacturers could be required to conduct new studies Sep 11, 2017
<乌鸦传媒>Lymphoma Case Reported in MS Patient on Aubagio First case in medical literature, more found in global surveillance reports Jul 07, 2017
<乌鸦传媒>PPAR-Gamma Drug May Work in MS In phase II study, drug diminished inflammatory lesions & cortical atrophy May 30, 2017
<乌鸦传媒>McDonald Criteria for MS May Incorporate CSF Testing Revision committee finds OCB testing may be useful in specific cases May 25, 2017
<乌鸦传媒>NEPAD: Better Endpoint for Progressive MS Trials? Tweak to 'no evidence of disease activity' standard stiffens criteria for progression May 02, 2017
